Effect of LINC00346/miR-637/NLRP1 on improving atherosclerosis by regulating endothelial autophagy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300067892

Enrollment

Unknown

Registered

2023-01-30

Start date

2023-02-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

CAD group :Peripheral arterial blood was drawn

non-CAD group:Peripheral arterial blood was drawn

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. Sign a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Tumor; 2. Acute and chronic infection; 3. severe liver and kidney dysfunction; 4. Malignant diseases of the blood system; 5. Pregnancy; 6. Cardiac arrest or tracheal intubation; 7. Coagulation dysfunction or low platelets.

Design outcomes

Primary

Measure	Time frame
LINC00346;miR-637;Sensitivity;Specificity;likelihood ratio;	—

Countries

China

Contacts

Public ContactWang Fangfang

The Second People's Hospital of Changzhou

lightyearwff@163.com+86 13815055302

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026